For the control of clinical signs associated with Equine Cushing’s Disease in horses. Active Ingredients: pergolide mesylate Directions for User: Prascend Tablets should not be crushed due to the potential for increased human exposure and care should be taken to minimize exposure when splitting tablets. The tablets are scored and the calculated dosage should be provided to the nearest one-half tablet increment. For equine use only. Special Precautions: Keep this and all medications out of the reach of children. Prascend should not be administered by persons who have had adverse reactions to ergotamine or other ergot derivatives. Pregnant or lactating women should wear gloves when administering this product. It has been reported that pergolide tablets may cause eye irritation, an irritating smell, or headache when Prascend Tablets are split or crushed. Prascend Tablets should not be crushed due to the potential for increased human exposure and care should be taken to minimize exposure when splitting tablets. Consult a physician in case of accidental ingestion by humans. Rebate Details: There may be savings available! Rebates can be redeemed online at BoehringerIngelheimEquineRebates.com after order is received.
